SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-23-005145
Filing Date
2023-03-30
Accepted
2023-03-30 17:18:04
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20230330xs3.htm S-3 457634
2 EX-4.10 tmb-20230330xex4d10.htm EX-4.10 409701
3 EX-5.1 tmb-20230330xex5d1.htm EX-5.1 51367
4 EX-23.1 tmb-20230330xex23d1.htm EX-23.1 2033
5 EX-FILING FEES tmb-20230330xexfilingfees.htm EX-FILING FEES 57649
6 GRAPHIC tmb-20230330xex5d1001.jpg GRAPHIC 4821
7 GRAPHIC tmb-20230330xs3006.jpg GRAPHIC 8743
  Complete submission text file 0001558370-23-005145.txt   998361
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271006 | Film No.: 23781801
SIC: 2834 Pharmaceutical Preparations